Pharmacokinetic/pharmacodynamic analysis
✍
A. I. Daud; C. Xu; W.-J. Hwu; P. Urbas; S. Andrews; N. E. Papadopoulos; L. C. Fl
📂
Article
📅
2010
🏛
Springer
🌐
English
⚖ 369 KB
## Purpose High-dose pegylated interferon α-2b (peginterferon α-2b) significantly decreased disease recurrence in patients with resected stage III melanoma in a clinical study. We investigated the pharmacokinetics (PK) and safety of high-dose peginterferon α-2b in patients with high-risk melanoma.